MannKind Corporation competitors and similar companiesClear all

MannKind Corporation's competitors and similar companies include Amgen, Assertio, Lexicon Pharmaceuticals and Eli Lilly.
MannKind Corporation
MannKind Corporation
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Assertio
Assertio
Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Eli Lilly
Eli Lilly
Eli Lilly and Company is a company that discovers, develops, manufactures, and markets pharmaceutical products.
Founding Date
Founding Date
1991
Founding Date
1980
Founding Date
1995
Founding Date
1995
Founding Date
1876
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Westlake Village, US HQ
Danbury, US
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Machelen, BE
Santo Amaro, BR
see more
Locations
Lake Forest, US HQ
Locations
The Woodlands, US HQ
Jersey, JE
Atlanta, US
Bernards, US
Birmingham, US
Boston, US
Charlotte, US
see more
Locations
Indianapolis, US HQ
Melrose Park, AU
Wien, AT
Brussel, BE
São Paulo, BR
Toronto, CA
Las Condes, CL
see more
Employees
Employees
2323% increase
Employees
24,200
Employees
2778% decrease
Employees
20216% increase
Employees
35,000
Valuation ($)
Valuation ($)
1.2 b
Valuation ($)
161.1 b
Valuation ($)
138.4 m
Valuation ($)
300.8 m
Valuation ($)
351.9 b
Twitter followers
Twitter followers
2.7 k
Twitter followers
124.8 k
Twitter followers
N/A
Twitter followers
292
Twitter followers
139.8 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
94
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
19
Number of tweets (last 30 days)
25
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
10.4
Average likes per tweet (last 30 days)
6.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
487.2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
97.87%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
73.68%
Percentage of tweets with engagement (last 30 days)
44%
Alexa Website Rank
Alexa Website Rank
478367
Alexa Website Rank
118547
Alexa Website Rank
N/A
Alexa Website Rank
472601
Alexa Website Rank
84618
Employee Rating
Employee Rating
3.2
Employee Rating
4.1
Employee Rating
2.6
Employee Rating
3.5
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
$75.4m (FY, 2021)
Revenue (est.)
$26b (FY, 2021)
Revenue (est.)
$111m (FY, 2021)
Revenue (est.)
$298k (FY, 2019)
Revenue (est.)
$28.3b (FY, 2021)
Cost of goods
Cost of goods
$16.8m (FY, 2021)
Cost of goods
$6.5b (FY, 2021)
Cost of goods
$15.8m (FY, 2021)
Cost of goods
N/A
Cost of goods
$7.3b (FY, 2021)
Gross profit
Gross profit
N/A
Gross profit
$19.5b (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Gross profit
$21b (FY, 2021)
Net income
Net income
($80.9m) (FY, 2021)
Net income
$5.9b (FY, 2021)
Net income
($1.3m) (FY, 2021)
Net income
($87.8m) (FY, 2019)
Net income
$5.6b (FY, 2021)

Operating

Countries
Countries
N/A
Countries
100 (FY, 2020)
Countries
N/A
Countries
N/A
Countries
120 (FY, 2021)
Patents (US)
Patents (US)
N/A
Patents (US)
31 (FY, 2020)
Patents (US)
12 (FY, 2020)
Patents (US)
N/A
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
27 (FY, 2019)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
8 (FY, 2021)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
10 (FY, 2021)
Products
Products
N/A
Products
N/A
Products
8 (FY, 2020)
Products
1 (FY, 2016)
Products
N/A

Funding

Total funding raised
Total funding raised
$ 200m
Total funding raised
N/A
Total funding raised
$ 42.5m
Total funding raised
$ 244.7m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Amgen
HQ
Thousand Oaks, US
Employees
24,200

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company
Assertio
HQ
Lake Forest, US
Employees
27

Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.

View company
Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

View company
Eli Lilly
HQ
Indianapolis, US
Employees
35,000

Eli Lilly and Company is a company that discovers, develops, manufactures, and markets pharmaceutical products.

View company